tiprankstipranks
Trending News
More News >
Ascletis Pharma, Inc. (HK:1672)
:1672
Hong Kong Market

Ascletis Pharma, Inc. (1672) Income Statement

Compare
4 Followers

Ascletis Pharma, Inc. Income Statement

Last quarter (Q4 2024), Ascletis Pharma, Inc.'s total revenue was ¥641.50K, a decrease of -87.28% from the same quarter last year. In Q4, Ascletis Pharma, Inc.'s net income was ¥-85.31M. See Ascletis Pharma, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 1.28M¥ 56.60M¥ 54.09M¥ 76.88M¥ 35.00M
Gross Profit
¥ 735.00K¥ 25.99M¥ -24.69M¥ 39.17M¥ -23.50M
Operating Expenses
¥ 382.99M¥ 326.20M¥ 314.94M¥ 223.26M¥ 129.44M
Depreciation and Amortization
¥ 14.05M¥ 18.48M¥ 30.19M¥ 29.55M¥ 27.16M
EBITDA
¥ -390.58M¥ -126.09M¥ -284.50M¥ -169.35M¥ -181.94M
Operating Income
¥ -403.40M¥ -306.81M¥ -262.82M¥ -195.90M¥ -156.43M
Other Income/Expenses
¥ 102.47M¥ 162.10M¥ -52.03M¥ -3.12M¥ -56.30M
Pretax Income
¥ -300.94M¥ -144.72M¥ -314.84M¥ -199.02M¥ -209.24M
Net Income
¥ -300.94M¥ -144.72M¥ -366.71M¥ -202.14M¥ -262.05M
Per Share Metrics
Basic EPS
¥ -0.30¥ -0.13¥ -0.34¥ -0.18¥ -0.25
Diluted EPS
¥ -0.30¥ -0.13¥ -0.34¥ -0.18¥ -0.25
Weighted Average Shares Outstanding
1.00B 1.07B 1.09B 1.10B 1.04B
Weighted Average Shares Outstanding (Diluted)
1.00B 1.07B 1.09B 1.10B 1.04B
Currency in CNY

Ascletis Pharma, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis